Sulfuric Acid

Sulfuric Acid

SCHEMBL2909993

CC[N+](CC)(CC)Cc1ccccc1.CC[N+](CC)(CC)Cc1ccccc1.O=S(=O)([O-])[O-]

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.46
KDM4E B2RXH2 1/20 0.43
ALDH1A1 P00352 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
CHRNA7 P36544 2/20 0.42
CHRNB4 P30926 1/20 0.42
CHRNA3 P32297 1/20 0.42
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
LMNA P02545 1/20 0.41
CYP2D6 P10635 1/20 0.41
TSHR P16473 1/20 0.41
TAS2R10 Q9NYW0 1/20 0.41
BCHE P06276 2/20 0.40
ACHE P22303 2/20 0.40
TP53 P04637 2/20 0.39
PSIP1 O75475 1/20 0.39
DNM1 Q05193 1/20 0.38
FAAH O00519 1/20 0.38
PRSS1 P07477 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Sulfuric Acid SCHEMBL8721479 0.98 CYP1A2 (0.45) CYP1A2KDM4EALDH1A1TDP1CHRNA7
Sulfuric Acid SCHEMBL10541158 0.96 CYP1A2 (0.44) CYP1A2KDM4EALDH1A1TDP1CHRNA7
SCHEMBL330401 0.94 CYP1A2 (0.45) CYP1A2KDM4EALDH1A1TDP1CHRNA7
SCHEMBL331080 0.94 CYP1A2 (0.45) CYP1A2KDM4EALDH1A1TDP1CHRNA7
Thiosulfuric Acid SCHEMBL8422606 0.92 CYP1A2 (0.44) CYP1A2KDM4EALDH1A1TDP1CHRNA7
Thiosulfuric Acid SCHEMBL8422604 0.92 CYP1A2 (0.44) CYP1A2KDM4EALDH1A1TDP1CHRNA7
Sulfuric Acid SCHEMBL782175 0.92 CYP1A2 (0.44) CYP1A2KDM4EALDH1A1TDP1CHRNA7
Sulfuric Acid SCHEMBL10541168 0.91 KDM4E (0.44) CYP1A2KDM4EALDH1A1TDP1CHRNA7
Sulfuric Acid SCHEMBL27810236 0.91 CYP1A2 (0.43) CYP1A2KDM4EALDH1A1TDP1CHRNA7
SCHEMBL6619378 0.89 CYP1A2 (0.42) CYP1A2KDM4EALDH1A1TDP1CHRNA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104892521-B A kind of synthesis of alpha-amido acid compounds and purification process 河北威远生物化工有限公司 2018-04-24 CN claimed
CN-104892521-A Synthesis and purification method for alpha-amino acid compound HEBEI VEYONG BIO CHEM CO LTD 2015-09-09 CN claimed
US-20250204164-A1 DISPLAY DEVICE AND PHOTOSENSITIVE COMPOSITION TORAY INDUSTRIES, INC. (JP) 2025-06-19 US disclosed
CN-118923228-A Display device and photosensitive composition 东丽株式会社 2024-11-08 CN disclosed
WO-2023190218-A1 DISPLAY DEVICE AND PHOTOSENSITIVE COMPOSITION 東レ株式会社 2023-10-05 WO disclosed
WO-2021107047-A1 METHOD FOR PRODUCING 4-(AMINOMETHYL)CYCLOHEXANE CARBOXYLIC ACID 株式会社DNPファインケミカル 2021-06-03 WO disclosed
CN-104892521-B A kind of synthesis of alpha-amido acid compounds and purification process 河北威远生物化工有限公司 2018-04-24 CN disclosed
CN-104968704-A Process for producing polyarylate MITSUBISHI GAS CHEMICAL CO 2015-10-07 CN disclosed
CN-104892521-A Synthesis and purification method for alpha-amino acid compound HEBEI VEYONG BIO CHEM CO LTD 2015-09-09 CN disclosed
EP-1781646-B1 PROCESS FOR THE PREPARATION OF 11-(4-[2-(2-HYDROXYETHOXY)ETHYL]-1-PIPERAZINYL)DIBENZO[b,f][1,4]THIAZEPINE SK HOLDINGS CO LTD (KR) 2010-08-18 EP disclosed
US-7678902-B2 Process for the preparation of 11-(4-[2-(2-hydroxyethoxy)ethyl]-1-piperazinyl)dibenzo[b,f][1,4]thiazepine SK HOLDINGS CO., LTD. (KR) 2010-03-16 US disclosed
EP-1781646-A4 PROCESS FOR THE PREPARATION OF 11-(4-[2-(2-HYDROXYETHOXY)ETHYL]-I-PIPERAZINYL)DIBENZO[B,F][1,4]THIAZEPINE SK HOLDINGS CO LTD (KR) 2009-03-04 EP disclosed
US-20070225494-A1 Process for the Preparation of 11-(4-[2-(2-Hydroxyethoxy)Ethyl]-I-Piperazinyl)Dibenzo[b,f][I,4]Thiazepine SK CORPORATION (KR) 2007-09-27 US disclosed
EP-1781646-A1 PROCESS FOR THE PREPARATION OF 11-(4-[2-(2-HYDROXYETHOXY)ETHYL]-I-PIPERAZINYL)DIBENZO[B,F][1,4]THIAZEPINE SK Corporation (KR) 2007-05-09 EP disclosed
WO-2006001619-A1 PROCESS FOR THE PREPARATION OF 11-(4-[2-(2-HYDROXYETHOXY)ETHYL]-I-PIPERAZINYL)DIB ENZO[b,f][l,4]THIAZEPINE SK CORPORATION (KR) 2006-01-05 WO disclosed
US-20020103328-A1 Aromatic polycarbonate composition, production process therefor and molded product thereof TEIJIN LIMITED 2002-08-01 US disclosed
US-4891168-A Process for producing steroid derivatives NIPPON KAYAKU KABUSHIKI KAISHA (JP) 1990-01-02 US disclosed
EP-0261656-A1 A process for producing steroid derivatives NIPPON KAYAKU KABUSHIKI KAISHA (JP) 1988-03-30 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070225494-A1 Process for the Preparation of 11-(4-[2-(2-Hydroxyethoxy)Ethyl]-I-Piperazinyl)Dibenzo[b,f][I,4]Thiazepine TALDO1, QDPR, HDHD5 CYP1A2 136/4885KDM4E 775/4885ALDH1A1 299/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.